Equities Analysts Offer Predictions for ACHC FY2024 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities research analysts at Zacks Research increased their FY2024 earnings per share estimates for shares of Acadia Healthcare in a research note issued on Wednesday, December 18th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings of $3.39 per share for the year, up from their previous forecast of $3.37. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.77 EPS and Q4 2025 earnings at $0.99 EPS.

Several other equities research analysts have also issued reports on the company. Royal Bank of Canada reduced their price objective on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research note on Monday, November 18th. StockNews.com upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, December 19th. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. KeyCorp assumed coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Barclays reduced their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $75.44.

Acadia Healthcare Trading Up 0.5 %

NASDAQ:ACHC opened at $37.67 on Monday. The company has a market cap of $3.50 billion, a PE ratio of 12.35, a P/E/G ratio of 1.77 and a beta of 1.30. The business’s 50 day moving average is $43.03 and its two-hundred day moving average is $60.27. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.91 EPS.

Institutional Trading of Acadia Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. GAMMA Investing LLC increased its stake in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after acquiring an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in Acadia Healthcare during the 2nd quarter valued at $59,000. Covestor Ltd lifted its holdings in Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after acquiring an additional 1,018 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in Acadia Healthcare during the 3rd quarter worth about $86,000. Finally, Assetmark Inc. boosted its position in shares of Acadia Healthcare by 66.1% in the third quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock worth $94,000 after buying an additional 591 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.